Take (NSE:TAKE) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TAKE Take Ltd NSE:TAKE
31 GF Score
Price ₹20.31
GF Value ₹0.01
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Take Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

NSE:TAKE
31GF Score
Take Ltd NSE:TAKE
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Take (NSE:TAKE) Overvalued in 2026?

Based on GuruFocus' analysis, Take stock appears to be overvalued. The current stock price of ₹20.31 is trading 203000% above its estimated GF Value™ of ₹0.01. GuruFocus considers Take to be Significantly Overvalued.

Key valuation signals for NSE:TAKE:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹0.01 vs. price of ₹20.31 (203000% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the NSE:TAKE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Take Business Description

Other Exchanges 532890:India
Address No.56, Old No. 116, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Take Solutions Ltd is a technology solutions provider specializing in Life Sciences and Supply Chain Management services. The company offers integrated services including clinical research, generics support, regulatory affairs, pharmacovigilance, and data sciences. It supports pharmaceutical, biotech, and medical device companies to various countries with technology-backed solutions that enhance drug development and regulatory compliance. Revenue is driven by its broad portfolio of IT-enabled services focused on the life sciences industry and supply chain management, catering to a client base of innovators, generics manufacturers, and biotech firms.
31GF Score

Get the complete analysis for NSE:TAKE

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹20.31
Price
₹0.01
GF Value